Abstract
The knowledge about to which biomolecules a small molecule binds is highly valuable in the drug development process. Although analytical methods to dissect ligand-binding proteome have made substantial progress in the past decades, it is generally too costly, if not infeasible, to know where a small molecule binds at very high resolution. Computational prediction of binding partners of small chemical molecules has become a useful approach to evaluate their potential therapeutic applications or adverse effects. In this article two computational approaches that were adopted to perform target identification, namely, molecular docking and pharmacophore fitting, are reviewed. Both approaches enable the identification of key interactions between the biomolecules and the small molecules. Databases that can be used to further improve the implementation and the computational methods and to benchmark their performances are also included.
Keywords: target prediction, target identification, adverse effect, side effect, toxicity, drug design
Current Topics in Medicinal Chemistry
Title:Target Prediction of Small Molecules with Information of Key Molecular Interactions
Volume: 12 Issue: 17
Author(s): Jung-Hsin Lin
Affiliation:
Keywords: target prediction, target identification, adverse effect, side effect, toxicity, drug design
Abstract: The knowledge about to which biomolecules a small molecule binds is highly valuable in the drug development process. Although analytical methods to dissect ligand-binding proteome have made substantial progress in the past decades, it is generally too costly, if not infeasible, to know where a small molecule binds at very high resolution. Computational prediction of binding partners of small chemical molecules has become a useful approach to evaluate their potential therapeutic applications or adverse effects. In this article two computational approaches that were adopted to perform target identification, namely, molecular docking and pharmacophore fitting, are reviewed. Both approaches enable the identification of key interactions between the biomolecules and the small molecules. Databases that can be used to further improve the implementation and the computational methods and to benchmark their performances are also included.
Export Options
About this article
Cite this article as:
Lin Jung-Hsin, Target Prediction of Small Molecules with Information of Key Molecular Interactions, Current Topics in Medicinal Chemistry 2012; 12 (17) . https://dx.doi.org/10.2174/156802612804547362
DOI https://dx.doi.org/10.2174/156802612804547362 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Real Code of Leonardo da Vinci
Current Cardiology Reviews Towards Newer Molecular Targets for Chronic Diabetic Complications
Current Vascular Pharmacology Discovery of Chromen-7-yl Furan-2-Carboxylate as a Potent and Selective Factor XIa Inhibitor
Cardiovascular & Hematological Agents in Medicinal Chemistry Serpins for Diagnosis and Therapy in Cancer
Cardiovascular & Hematological Disorders-Drug Targets Potential Use of Modulators of Oxidative Stress as Add-on Therapy in Patients with Anxiety Disorders
Current Drug Targets Aging Liver: Can Exercise be a Better Way to Delay the Process than Nutritional and Pharmacological Intervention? Focus on Lipid Metabolism
Current Pharmaceutical Design Patent Selections:
Recent Patents on CNS Drug Discovery (Discontinued) Recent Patents on Biomedical Devices and Nanomaterials for Hyperthermal Therapy of Cancer
Recent Patents on Nanomedicine Preclinical Pharmacokinetics: An Approach Towards Safer and Efficacious Drugs
Current Drug Metabolism Polyphenols from Red Wine Modulate Immune Responsiveness: Biological and Clinical Significance
Current Pharmaceutical Design Role of Bradykinin in the Regulation of Endothelial Nitric Oxide Synthase Expression by Cardiovascular Drugs
Current Pharmaceutical Design Nucleolar Localization Signals of LIM Kinase 2 Function as a Cell- Penetrating Peptide
Protein & Peptide Letters Cannabinoid System as a Potential Target for Drug Development in the Treatment of Cardiovascular Disease
Current Vascular Pharmacology Diabetes without Manifest Cardiovascular Disease: A Novel Approach in Risk Stratification and Treatment Selection
Current Diabetes Reviews Enriched Environment Prevents Cognitive Impairment and Tau hyperphosphorylation after Chronic Cerebral Hypoperfusion
Current Neurovascular Research Boosting Interleukin-10 Production: Therapeutic Effects and Mechanisms
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Nanomedicine and its Application in Treatment of Microglia-mediated Neuroinflammation
Current Medicinal Chemistry Scrutinizing different EEG-Based Mechanisms for Motor Control and Rehabilitation of Lower Limb Disabilities
Neuroscience and Biomedical Engineering (Discontinued) NQDI 1, An Inhibitor of ASK1 Attenuates Acute Ischemic Renal Injury by Modulating Oxidative Stress and Cell Death
Cardiovascular & Hematological Agents in Medicinal Chemistry T9-T10 Osteomyelitis, Epidural Abscess and Cord Compression Secondary to <i>Mycobacterium abscessus</i>: A Case Report
Infectious Disorders - Drug Targets